Telecom operator Bharti Airtel and Apollo Hospitals have conducted India’s first 5G-powered, artificial intelligence-led colon cancer detection study, the telecom company announced on Thursday.
The study was conducted using AI on Airtel’s 5G technology with extremely low latency and high processing capacities, which allowed the colorectal cancer to be detected much faster and with greater accuracy, she added.
“At Airtel we are ready to lead this transformation and have demonstrated this by conducting the first colonoscopy trials in India. Healthcare is one of the most promising use cases for 5G and we are excited to partner with Apollo Hospitals, AWS, HealthNet Global and Avesha,” said Ajay Chitkara, CEO and Director of Airtel Business.
HealthNet Global, AWS, and Avesha were the other three companies that collaborated on this study.
The data was processed in real-time by Avesha edge inferencing applications on AWS platforms, resulting in faster analysis.
“The AI-assisted colonoscopy polyp detection study will help physicians improve the quality of patient care, improve the accuracy of detection rates by correctly capturing information and reducing errors. 5G, edge computing and artificial intelligence can significantly improve patient outcomes by helping in the correct and timely diagnosis,” the statement added.
According to the current protocol, colon cancer is detected through a manual colonoscopy procedure, which requires close attention and time from physicians for accurate detection. The standard procedure takes about 30 to 40 minutes.
“By improving the doctor’s ability to recognize, AI has been shown to improve doctor’s accuracy. Early detection and removal of polyps can easily prevent them from becoming cancerous. Our patient-centric approach keeps us on the lookout for technologies that can improve outcomes,” said Apollo Hospitals Group, Joint Managing Director, Sangita Reddy.